Does dapagliflozin control postprandial blood glucose?
Jan 04, 2024
Source: Cainiu Health
Introduction
Under normal circumstances, dapagliflozin can help control postprandial blood glucose and should be taken as directed by a physician. Dapagliflozin is an SGLT-2 inhibitor, and its mechanism for controlling postprandial blood glucose primarily involves inhibiting the SGLT-2 transporter protein in the kidneys. Patients should still pay attention to lifestyle modifications such as diet and exercise to achieve more comprehensive and effective control of postprandial blood glucose.
达格列净常见剂型为片剂,一般情况下,达格列净可以控制餐后血糖,需遵医嘱服用Medicine。
达格列净是一种SGLT-2抑制剂,其控制餐后血糖的机制主要源于对Kidneys中的SGLT-2转运蛋白的抑制作用。
达格列净通过干预肾小管对葡萄糖的重吸收过程,引导多余的葡萄糖随尿液排出,从而降低体内葡萄糖浓度,尤其是在餐后这个血糖波动较为明显的时间段。
在胰岛素抵抗或相对胰岛素分泌不足的DiabetesPatient中,餐后血糖升高是一个常见的问题。达格列净通过减少肾小管对葡萄糖的再吸收,有效降低了体内葡萄糖水平,特别是在进食后。达格列净的作用机制独特,其强调了通过Kidneys途径排出多余的葡萄糖。
但是Diabetes管理是一个综合性的过程,达格列净作为其中的一种Medicine,应在Doctor的指导下使用。Patient仍需注意Diet、Exercise等Life方式的调整,以实现更全面、有效的餐后血糖控制。